Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alois Kozubik

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Mitochondrion|November 9, 2010
MAC'09, Otto and us…Jiri Neuzil, Ladislav Andera, Alois Kozubik
Current Pharmaceutical Biotechnology|December 29, 2011
Regulation of the metabolism of polyunsaturated Fatty acids and butyrate in colon cancer cellsJirina Hofmanova, Alena Hyrslova Vaculova, Alois Kozubik
Human Mutation|July 22, 2009
Molecular pathology of the fibroblast growth factor familyPavel Krejci, Jirina Prochazkova, Vitezslav Bryja, et al.
Stem Cells (Dayton, Ohio)|August 13, 2013
Expression of FGF19 in human embryonic stem cellsPavel Krejci, Michaela Kunova, Iva Kubikova, et al.
Cancer Investigation|June 18, 2004
In vitro proliferation of fibrosarcoma cells depends on intact functions of lipoxygenases and cytochrome P-450-monooxygenaseZuzana Hoferová, Karel Soucek, Jirina Hofmanová, et al.
Cellular Signalling|October 28, 2008
Fibroblast growth factor inhibits interferon gamma-STAT1 and interleukin 6-STAT3 signaling in chondrocytesPavel Krejci, Jirina Prochazkova, Vitezslav Bryja, et al.
Oncology Letters|June 29, 2012
Apoptosis inhibitor 5 (API-5; AAC-11; FIF) is upregulated in human carcinomas in vivoLenka Koci, Katarina Chlebova, Martina Hyzdalova, et al.
Bone|April 6, 2010
FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescencePavel Krejci, Jirina Prochazkova, Jiri Smutny, et al.
Plos One|December 18, 2008
Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilagePavel Krejci, Lisa Salazar, Tamara A Kashiwada, et al.
Human Molecular Genetics|October 24, 2015
Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromesIva Gudernova, Iva Vesela, Lukas Balek, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Mitochondrion|November 9, 2010
MAC'09, Otto and us…Jiri Neuzil, Ladislav Andera, Alois Kozubik
Current Pharmaceutical Biotechnology|December 29, 2011
Regulation of the metabolism of polyunsaturated Fatty acids and butyrate in colon cancer cellsJirina Hofmanova, Alena Hyrslova Vaculova, Alois Kozubik
Human Mutation|July 22, 2009
Molecular pathology of the fibroblast growth factor familyPavel Krejci, Jirina Prochazkova, Vitezslav Bryja, et al.
Stem Cells (Dayton, Ohio)|August 13, 2013
Expression of FGF19 in human embryonic stem cellsPavel Krejci, Michaela Kunova, Iva Kubikova, et al.
Cancer Investigation|June 18, 2004
In vitro proliferation of fibrosarcoma cells depends on intact functions of lipoxygenases and cytochrome P-450-monooxygenaseZuzana Hoferová, Karel Soucek, Jirina Hofmanová, et al.
Cellular Signalling|October 28, 2008
Fibroblast growth factor inhibits interferon gamma-STAT1 and interleukin 6-STAT3 signaling in chondrocytesPavel Krejci, Jirina Prochazkova, Vitezslav Bryja, et al.
Oncology Letters|June 29, 2012
Apoptosis inhibitor 5 (API-5; AAC-11; FIF) is upregulated in human carcinomas in vivoLenka Koci, Katarina Chlebova, Martina Hyzdalova, et al.
Bone|April 6, 2010
FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescencePavel Krejci, Jirina Prochazkova, Jiri Smutny, et al.
Plos One|December 18, 2008
Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilagePavel Krejci, Lisa Salazar, Tamara A Kashiwada, et al.
Human Molecular Genetics|October 24, 2015
Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromesIva Gudernova, Iva Vesela, Lukas Balek, et al.
Pageof 2